RRM2 and breast cancer: SILAC-MS quantifies lincNMR and boosts tumor proliferation through a YBX1-RRM2-TYMS-TK1 axis in liver, lung, and breast cancer cell lines, while GLCC1 mediates metabolic reprogramming in colorectal cancer and HULC (Highly Upregulated in Liver Cancer) [34,56].